Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-06 Sale |
2022-01-10 4:19 pm |
T2 Biosystems Inc. | TTOO | Ahuja Aparna Chief Medical Officer |
61,988 | $0.48 | $29,754 | 107,611 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 4:00 pm |
T2 Biosystems Inc. | TTOO | McDonough John Director |
18,182 | $1.16 | $21,091 | 516,386 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 4:00 pm |
T2 Biosystems Inc. | TTOO | CUMMING JOHN W Director |
18,182 | $1.16 | $21,091 | 50,852 (Direct) |
View |
| 2021-03-25 Sale |
2021-03-25 3:17 pm |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
8,758 | $1.56 | $13,662 | 106,589 (Direct) |
View |
| 2021-03-17 Sale |
2021-03-18 4:34 pm |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
12,494 | $1.86 | $23,239 | 74,420 (Direct) |
View |
| 2021-03-17 Sale |
2021-03-18 4:34 pm |
T2 Biosystems Inc. | TTOO | Pare Anthony Chief Commercial Officer |
9,620 | $1.84 | $17,701 | 31,612 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-21 Tax Withholding(A) |
2022-03-29 4:17 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
3,775 | $0.466 | 651,639 (Direct) |
View |
| 2022-02-20 Option Award(A) |
2022-03-29 4:17 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
600,000 | $0 | 651,639 (Direct) |
View |
| 2022-02-21 Exercise(A) |
2022-03-29 4:17 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
10,000 | $0 | 651,639 (Direct) |
View |
| 2022-03-24 Tax Withholding |
2022-03-28 6:42 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
8,790 | $0.4409 | 173,318 (Direct) |
View |
| 2022-03-24 Exercise |
2022-03-28 6:42 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
16,666 | $0 | 173,318 (Direct) |
View |
| 2022-02-24 Exercise(A) |
2022-03-28 6:39 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
145,719 | $0 | 440,214 (Direct) |
View |
| 2022-02-24 Tax Withholding(A) |
2022-03-28 6:39 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
76,867 | $0.4488 | 440,214 (Direct) |
View |
| 2022-02-21 Tax Withholding(A) |
2022-03-28 6:34 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
5,275 | $0.466 | 679,923 (Direct) |
View |
| 2022-02-20 Option Award(A) |
2022-03-28 6:34 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
600,000 | $0 | 679,923 (Direct) |
View |
| 2022-02-21 Exercise(A) |
2022-03-28 6:34 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
10,000 | $0 | 679,923 (Direct) |
View |
| 2022-02-24 Exercise |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
145,719 | $0 | 427,635 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
55,008 | $0.4488 | 427,635 (Direct) |
View |
| 2022-02-24 Exercise |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
336,976 | $0 | 495,731 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
88,878 | $0.4488 | 495,731 (Direct) |
View |
| 2022-02-24 Exercise |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
145,719 | $0 | 430,214 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
76,867 | $0.4488 | 430,214 (Direct) |
View |
| 2022-02-24 Exercise |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sperzel John J III See Remarks |
333,333 | $0 | 858,440 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sperzel John J III See Remarks |
141,560 | $0.4488 | 858,440 (Direct) |
View |
| 2021-02-21 Tax Withholding |
2022-02-23 7:42 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
5,275 | $0.466 | 679,145 (Direct) |
View |
| 2022-02-20 Option Award |
2022-02-23 7:42 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
600,000 | $0 | 679,145 (Direct) |
View |
| 2022-02-21 Exercise |
2022-02-23 7:42 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Barclay Alec Chief Operations Officer |
20,000 | $0 | 679,145 (Direct) |
View |
| 2022-02-21 Tax Withholding |
2022-02-23 7:40 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
3,775 | $0.466 | 645,485 (Direct) |
View |
| 2022-02-20 Option Award |
2022-02-23 7:40 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
600,000 | $0 | 645,485 (Direct) |
View |
| 2022-02-21 Exercise |
2022-02-23 7:40 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sprague John M Chief Financial Officer |
10,000 | $0 | 645,485 (Direct) |
View |
| 2022-02-21 Tax Withholding |
2022-02-23 7:28 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
5,275 | $0.466 | 669,923 (Direct) |
View |
| 2022-02-20 Option Award |
2022-02-23 7:28 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
600,000 | $0 | 669,923 (Direct) |
View |
| 2022-02-21 Exercise |
2022-02-23 7:28 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
10,000 | $0 | 669,923 (Direct) |
View |
| 2022-02-20 Option Award |
2022-02-23 7:22 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-02-20 Option Award |
2022-02-23 6:29 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sperzel John J III See Remarks |
2,400,000 | $0 | 2,400,000 (Direct) |
View |
| 2022-02-20 Option Award |
2022-02-23 6:28 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Ahuja Aparna Chief Medical Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-06 1:01 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Ahuja Aparna Chief Medical Officer |
153,664 | $0 | 476,927 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 4:02 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Toft Robin Director |
32,258 | $0 | 54,985 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 4:01 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
77,519 | $0 | 132,504 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 4:01 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
32,258 | $0 | 132,504 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | LIEBMAN SEYMOUR Director |
77,519 | $0 | 239,416 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | LIEBMAN SEYMOUR Director |
32,258 | $0 | 239,416 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 3:59 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
77,519 | $0 | 132,504 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 3:59 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
32,258 | $0 | 132,504 (Direct) |
View |
| 2022-01-01 Exercise |
2022-01-04 3:57 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Elsbree David B Director |
32,258 | $0 | 212,981 (Direct) |
View |
Ownership |
2021-11-15 12:43 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Giffin Brett A. Chief Commercial Officer |
0 | $0 | 500,000 (Direct) |
View |
Ownership |
2021-11-05 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Adams Laura Lee Director |
0 | $0 | 109,836 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-10 11:11 am |
N/A N/A |
T2 Biosystems Inc. | TTOO | Toft Robin Director |
22,727 | $0 | 68,181 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
22,727 | $0 | 68,181 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-09 4:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
22,727 | $0 | 68,181 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 3:01 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Saunders Ninfa Director |
73,224 | $0 | 73,224 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 3:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | CUMMING JOHN W Director |
81,967 | $0 | 196,455 (Direct) |
View |
| 2021-06-25 Exercise |
2021-06-29 3:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | CUMMING JOHN W Director |
45,454 | $0 | 196,455 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 3:00 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Bernard Thierry Director |
73,224 | $0 | 73,224 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 2:59 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | LIEBMAN SEYMOUR Director |
73,224 | $0 | 248,317 (Direct) |
View |
| 2021-06-25 Exercise |
2021-06-29 2:59 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | LIEBMAN SEYMOUR Director |
45,454 | $0 | 248,317 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 2:56 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | McDonough John Director |
81,967 | $0 | 661,989 (Direct) |
View |
| 2021-06-25 Exercise |
2021-06-29 2:56 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | McDonough John Director |
45,454 | $0 | 661,989 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 2:56 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Elsbree David B Director |
73,224 | $0 | 299,401 (Direct) |
View |
| 2021-06-25 Exercise |
2021-06-29 2:56 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Elsbree David B Director |
45,454 | $0 | 299,401 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 2:55 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Toft Robin Director |
73,224 | $0 | 73,224 (Direct) |
View |
| 2021-03-24 Exercise |
2021-03-25 3:17 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Gibbs Michael Terrence General Counsel |
16,667 | $0 | 106,589 (Direct) |
View |
| 2021-02-24 Option Award(A) |
2021-03-19 09:44 am |
N/A N/A |
T2 Biosystems Inc. | TTOO | Sperzel John J III President and CEO |
1,000,000 | $0 | 1,000,000 (Direct) |
View |
| 2021-03-14 Exercise |
2021-03-16 12:41 pm |
N/A N/A |
T2 Biosystems Inc. | TTOO | Pare Anthony Chief Commercial Officer |
17,500 | $0 | 76,232 (Direct) |
View |